Partner article:
From collaboration to Phase III readiness
We are proud to share the progress of our collaboration with OncoZenge. Their pivotal Phase III trial of BupiZenge™ has now received European regulatory approval, an important milestone in bringing a new treatment closer to patients.
A key success factor has been building a strong sponsor oversight model. Through close collaboration, PharmaRelations has supported across critical areas including program management, regulatory affairs, QA, biostatistics, and medical writing.
This integrated approach has enabled OncoZenge to maintain strategic control while accessing the right expertise at the right time, ensuring both flexibility and quality.
Want to see how this was built in practice and what you can apply
in your organization?
